We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.9B
AUM Growth
+$317M
Cap. Flow
-$92.4M
Cap. Flow %
-1.56%
Top 10 Hldgs %
47.94%
Holding
165
New
49
Increased
48
Reduced
28
Closed
27

Top Sells

Rank Stock Value
1
CPB icon
Campbell Soup
CPB
+$59.8M
2
LULU icon
lululemon athletica
LULU
+$56.9M
3
AMZN icon
Amazon
AMZN
+$46.6M
4
TH icon
Target Hospitality
TH
+$46.3M
5
ALKS icon
Alkermes
ALKS
+$43.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.61%
2 Consumer Discretionary 7.96%
3 Consumer Staples 6.71%
4 Communication Services 3.41%
5 Technology 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGSW
126
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$745K 0.01%
1,285,715
DBGIW
127
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$557K 0.01%
7,229
QTEXW
128
DELISTED
QTREX Quantum Warrant
QTEXW
$492K 0.01%
+600,000
New +$590K
SBEV.WS
129
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$479K 0.01%
904,000
+29,000
+3% +$26.2K
GROY.WS
130
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$448K 0.01%
448,000
NLSPW
131
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$413K 0.01%
500,000
GMVDW
132
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$394K 0.01%
1,000,000
AGRIW
133
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$330K 0.01%
+600,000
New +$479K
DRMAW icon
134
Dermata Therapeutics Warrant
DRMAW
$16.3K
$270K ﹤0.01%
+325,000
New +$334K
PETVW
135
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$154K ﹤0.01%
+200,000
New +$170K
SYTAW
136
DELISTED
Siyata Mobile Warrant
SYTAW
$102K ﹤0.01%
150,000
SQLLW
137
DELISTED
SeqLL Inc. Warrant
SQLLW
$53K ﹤0.01%
+50,000
New +$58.3K
AYTU icon
138
AYTU BioPharma
AYTU
$24.7M
-67,119
Closed -$6.72M
BCTX
139
Briacell Therapeutics
BCTX
$30.4M
-3,802
Closed -$3.04M
BIO icon
140
Bio-Rad Laboratories Class A
BIO
$9.31B
-18,000
Closed -$11.6M
CPB icon
141
Campbell Soup
CPB
$6.87B
-1,312,000
Closed -$59.8M
CROX icon
142
Crocs
CROX
$6.58B
-117,300
Closed -$13.7M
DTSTW
143
DELISTED
Data Storage Corp Warrant
DTSTW
-15,000
Closed -$18K
DXCM icon
144
DexCom
DXCM
$31.2B
-232,000
Closed -$24.8M
FL
145
DELISTED
Foot Locker
FL
-505,187
Closed -$31.1M
HBI
146
DELISTED
Hanesbrands
HBI
-800,000
Closed -$14.9M
KMB icon
147
Kimberly-Clark
KMB
$37.3B
-148,000
Closed -$19.8M
KOF icon
148
Coca-Cola Femsa
KOF
$22.7B
-492,000
Closed -$26M
KPRX icon
149
Kiora Pharmaceuticals
KPRX
$11.3M
-9,296
Closed -$12.2M
LEXXW
150
DELISTED
Lexaria Bioscience Warrant
LEXXW
-361,905
Closed -$908K

Similar funds

Armistice Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Armistice Capital held 165 positions worth $5.9B, up 5.7% from $5.59B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital's Q3 2021 filing shows 49 new, 48 increased, 28 reduced and 27 closed positions. Its largest new stake was Five Below: 381,266 shares worth $67.4M. The largest sale was Campbell Soup, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q3 2021 buy was Five Below: 381,266 shares worth $67.4M.
  • Armistice Capital added most to Incyte in Q3 2021, an estimated $107M increase.
  • Armistice Capital's biggest Q3 2021 reduction was Amazon, cutting an estimated $46.6M.
  • Armistice Capital fully exited Campbell Soup in Q3 2021, selling an estimated $59.8M.
  • Armistice Capital's ten largest holdings make up 48% of its $5.9B portfolio in Q3 2021.
  • Armistice Capital opened 49 new positions and closed 27 in Q3 2021.
  • Armistice Capital's portfolio value rose 5.7% quarter-over-quarter to $5.9B.

Based on Armistice Capital's 13F filing for Q3 2021, filed 15 Nov 2021.